Number of doses | Placebo N = 31 | Rebamipide 2% N = 31 | Rebamipide 4% N = 32 |
---|---|---|---|
297 ± 168 | 278 ± 171 | 343 ± 135 | |
Retention compliance,a n (%) | |||
≥ 80% | 18 (58.1) | 18 (58.1) | 25 (78.1) |
≥ 50% to <80% | 6 (19.4) | 7 (22.6) | 6 (18.8) |
< 50% | 7 (22.6) | 6 (19.4) | 1 (3.1) |
Swallowing rate,b n (%) | |||
≥ 80% | 9 (29.0) | 13 (41.9) | 14 (43.8) |
≥ 50% to <80% | 6 (19.4) | 8 (25.8) | 6 (18.8) |
< 50% | 16 (51.6) | 10 (32.3) | 12 (37.5) |
Total doses of cisplatin (mg/m2) | 213 ± 73 | 192 ± 66 | 233 ± 61 |
The total radiation dose (Gy) | 58 ± 20 | 55 ± 22 | 63 ± 13 |
Frequency of interruption of radiotherapy | |||
0 times | 28 (90.3) | 29 (93.5) | 30 (93.8) |
1 times | 3 (9.7) | 2 (6.5) | 1 (3.1) |
2 times | 0 | 0 | 0 |
3 times | 0 | 0 | 0 |